The Gluten-Free Brief

Latest celiac disease news: promising drug trials, muscle health research, pediatric follow-up, Finland’s financial support, and gluten-related recalls.

The latest gluten-free news: celiac diagnosis and testing, new Polish guidelines, diabetes research, biopsy findings and gluten and allergen recalls.

The latest gluten-free news: regulatory updates, celiac disease research, expanded adult care, and recalls in the U.S., Canada and Spain.

Celiac drug trial results, updated prevalence data, a Brazilian labeling case, school guidance, and recalls — the latest in gluten-free research and policy.

A Cleveland Clinic AI model reaches 97% accuracy distinguishing celiac from normal biopsies, while a Norwegian study finds evidence of historical misdiagnosis. Plus long-term outcomes, COVID-19 risk and recalls.

Spain funds gluten-free diets, Sydney Airport’s labeling faces scrutiny, and four bills advance in Congress. Plus a drug acquisition and product recalls.

Tunisia funds gluten-free diets, Codex sets a global “may contain” gluten standard, and the UK updates celiac diagnosis guidance. Plus recalls.

The latest gluten-free news from around the world: a New Zealand hospital case, new celiac disease research from Norway, advocacy stories from Malta and Spain, and recent gluten-related recalls in the UK and France.

June’s gluten-free news: FDA’s labeling review, Virginia’s takeout law, beer testing gaps, a probiotic yeast study, and recalls in three countries.

Celiac disease raises the risk of death, heart disease, and organ failure — and two new studies published this week put the numbers on paper for the first time in the U.S. This edition also covers a landmark labeling bill, a stalled compensation law in Spain, and how major league baseball is stepping up for the celiac community.